AG
EBS icon

Advisor Group’s Emergent Biosolutions EBS Stock Holding History

Advisor Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$282K Sell
5,238
-766
-13% -$41.5K ﹤0.01% 2120
2019
Q3 		$314K Sell
6,004
-425
-7% -$19.8K ﹤0.01% 1974
2019
Q2 		$310K Sell
6,429
-743
-10% -$35.6K ﹤0.01% 1969
2019
Q1 		$362K Buy
7,172
+170
+2% +$10K ﹤0.01% 1825
2018
Q4 		$415K Buy
7,002
+860
+14% +$55.4K ﹤0.01% 1543
2018
Q3 		$405K Buy
6,142
+2,507
+69% +$146K ﹤0.01% 1625
2018
Q2 		$183K Sell
3,635
-8
-0.2% -$417 ﹤0.01% 2040
2018
Q1 		$192K Buy
3,643
+2,008
+123% +$100K ﹤0.01% 2012
2017
Q4 		$76K Buy
1,635
+125
+8% +$5.26K ﹤0.01% 2781
2017
Q3 		$61K Buy
1,510
+788
+109% +$28.5K ﹤0.01% 2785
2017
Q2 		$24K Buy
+722
New +$22.3K ﹤0.01% 3379
2016
Q4 		– Sell
-139
Closed -$4K – 4526
2016
Q3 		$4K Sell
139
-1,980
-93% -$57.5K ﹤0.01% 3972
2016
Q2 		$59K Buy
+2,119
New +$83.1K ﹤0.01% 2298

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Group's EBS Position: Q4 2019 in Review

Advisor Group reduced its Emergent Biosolutions (EBS) stake by 13% in Q4 2019, selling an estimated $41.5K and leaving 5,238 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

Advisor Group first reported a position in EBS in Q2 2016 and has held it in 13 quarters since. The position peaked at $415K in Q4 2018. 236 funds tracked by Wall St. Rank hold EBS as of Q4 2019.

  • Advisor Group held 5,238 shares of Emergent Biosolutions worth $282K as of Q4 2019.
  • Advisor Group sold 766 Emergent Biosolutions shares in Q4 2019, an estimated $41.5K.
  • Emergent Biosolutions made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2120 holding.
  • Advisor Group first reported a position in Emergent Biosolutions in Q2 2016 and has held it in 13 quarters since.
  • Advisor Group's Emergent Biosolutions position peaked at $415K in Q4 2018.
  • 236 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.